Literature DB >> 20874420

A tailored dose of tenofovir could reduce its impact on bone mass in HIV Type 1-infected children and adolescents: a report from 5 years of clinical experience.

Raffaella Rosso, Arianna Parodi, Chiara Torrisi, Francesca De Terlizzi, Claudio Viscoli, Marina Vignolo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20874420     DOI: 10.1089/aid.2010.0122

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  2 in total

Review 1.  Renal and Bone Adverse Effects of a Tenofovir-Based Regimen in the Treatment of HIV-Infected Children: A Systematic Review.

Authors:  Rose I Okonkwo; Anita E Weidmann; Emmanuel E Effa
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

2.  Bone health in HIV-infected children, adolescents and young adults: a systematic review.

Authors:  Stephen M Arpadi; Stephanie Shiau; Charlotte Marx-Arpadi; Michael T Yin
Journal:  J AIDS Clin Res       Date:  2014-11-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.